Sareum Holdings PLC Sustainability Reports
Sareum Holdings PLC is a clinical-stage biotechnology company focused on the discovery and development of small molecule kinase inhibitors for the treatment of autoimmune diseases and cancer. Its lead programs target the JAK kinase family, specifically focusing on advancing therapeutic candidates into clinical-stage trials.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
ISIN: GB00B02RFS12
12 reports from 2014 to 2025